Methylprednisolone
- Generic Name
- Methylprednisolone
- Brand Names
- Depo-medrol, Depo-medrol With Lidocaine, Hybrisil, Medrol, Medroloan Suik, Readysharp-p40, Readysharp-p80
- Drug Type
- Small Molecule
- Chemical Formula
- C22H30O5
- CAS Number
- 83-43-2
- Unique Ingredient Identifier
- X4W7ZR7023
- Background
Methylprednisolone is a prednisolone derivative glucocorticoid with higher potency than prednisone. It was first described in the literature in the late 1950s.
...
- Indication
Oral and intramuscular methylprednisolone are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, gastrointestinal, nervous system, and other disorders. Intra-articular and soft tissue injections are indicated for short term treatment of acute gouty arthritis, acute an...
- Associated Conditions
- Acute Gouty Arthritis, Acute Leukemia, Allergic Conjunctivitis (AC), Allergic corneal marginal ulcers, Alopecia Areata (AA), Ankylosing Spondylitis (AS), Aponeurosis contusion, Aspiration Pneumonitis, Asthma, Atopic Dermatitis, Autoimmune Hemolytic Anemia, Berylliosis, Bronchial Asthma, Bullous dermatitis herpetiformis, Chorioretinitis, Choroiditis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Contact Dermatitis, Degenerative Joint Disease, Dermatomyositis (DM), Discoid Lupus Erythematosus (DLE), Drug hypersensitivity reaction, Edema of the cerebrum, Epicondylitis, Erythroblastopenia, Gout, Hypercalcemia of Malignancy, Immune Thrombocytopenia (ITP), Inflammatory Reaction of the Cysts, Iridocyclitis, Iritis, Keloids Scars, Keratitis, Leukemias, Lichen Planus (LP), Lichen simplex chronicus, Loeffler's syndrome, Lymphoma, Meningitis caused by Mycobacterium Tuberculosis, Mycosis Fungoides (MF), Necrobiosis lipoidica diabeticorum, Nummular Dermatitis, Ocular Inflammation, Ophthalmia, Sympathetic, Optic Neuritis, Pemphigus, Perennial Allergic Rhinitis (PAR), Polymyositis, Posttraumatic Osteoarthritis, Primary adrenocortical insufficiency, Psoriatic Arthritis, Psoriatic plaque, Pure Red Cell Aplasia, Regional Enteritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile, Seasonal Allergic Rhinitis, Seborrheic Dermatitis, Eczematous, Secondary adrenocortical insufficiency, Secondary thrombocytopenia, Serum Sickness, Severe Seborrheic Dermatitis, Stevens-Johnson Syndrome, Systemic Lupus Erythematosus, Temporal Arteritis, Tendonitis exacerbated, Transfusion Reactions, Trichinosis, Ulcerative Colitis, Uveitis, Acute Bursitis, Acute Multiple sclerosis exacerbation, Acute nonspecific tenosynovitis, Acute rheumatic carditis, Anterior eye segment inflammation, Articular inflammation, Cystic tumors of aponeurosis, Cystic tumors of tendon, Disseminated Pulmonary Tuberculosis (TB), Exfoliative erythroderma, Fulminating Pulmonary Tuberculosis, Idiopathic eosinophilic pneumonias, Inflammatory dermatoses of the scalp, Localized Hypertrophic, Inflammatory, Infiltrated granuloma annulare lesions, Non-suppurative Thyroiditis, Severe Erythema multiforme, Severe Psoriasis, Subacute Bursitis, Symptomatic Sarcoidosis, Synovitis of osteoarthritis, Systemic Dermatomyositis, Varicella-zoster virus acute retinal necrosis
- Associated Therapies
- Palliative Treatment
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath